{"data": [{"news_url": "https://www.fool.com/investing/2020/02/26/modernas-vaccine-program-new-overshadows-earnings.aspx", "image_url": "https://cdn.snapi.dev/images/v1/r/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5600092fcoronavirusjpgw700opresize.jpg", "title": "Moderna's Vaccine Program News Overshadows Its Earnings Report", "text": "The financials were a sideshow as investors focused on the company's potential vaccines for the COVID-19 coronavirus and congenital cytomegalovirus.", "source_name": "The Motley Fool", "date": "Wed, 26 Feb 2020 15:48:00 -0500", "topics": ["earnings"], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://seekingalpha.com/article/4327456-moderna-inc-mrna-ceo-stephane-bancel-on-q4-2019-results-earnings-call-transcript", "image_url": "https://cdn.snapi.dev/images/v1/e/t/transcript18.jpg", "title": "Moderna, Inc. (MRNA) CEO St\u00e9phane Bancel on Q4 2019 Results - Earnings Call Transcript", "text": "Moderna, Inc. (MRNA) CEO St\u00e9phane Bancel on Q4 2019 Results - Earnings Call Transcript", "source_name": "Seeking Alpha", "date": "Wed, 26 Feb 2020 14:57:09 -0500", "topics": ["CallScript"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.zacks.com/stock/news/784855/4-healthcare-stocks-to-gain-as-coronavirus-threat-looms-large", "image_url": "https://cdn.snapi.dev/images/v1/i/g/biotech26.jpg", "title": "4 Healthcare Stocks to Gain as Coronavirus Threat Looms Large", "text": "Healthcare companies are trying to find a cure and contain the coronavirus outbreak. This keeps the industry in focus", "source_name": "Zacks Investment Research", "date": "Wed, 26 Feb 2020 09:08:00 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["INO", "MRNA", "NVAX", "VXRT"]}, {"news_url": "https://www.zacks.com/stock/news/784763/moderna-mrna-beats-earnings-estimates-in-q4-revenues-miss", "image_url": "https://cdn.snapi.dev/images/v1/t/k/biotech36.jpg", "title": "Moderna (MRNA) Beats Earnings Estimates in Q4, Revenues Miss", "text": "Moderna (MRNA) reports narrower-than expected loss in the fourth quarter. However, revenues miss estimates.", "source_name": "Zacks Investment Research", "date": "Wed, 26 Feb 2020 08:34:00 -0500", "topics": ["earnings"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.marketwatch.com/story/modernas-stock-climbs-as-coronavirus-vaccine-shipment-offsets-earnings-miss-2020-02-26", "image_url": "https://cdn.snapi.dev/images/v1/w/m/biotech17.jpg", "title": "Moderna's stock climbs as coronavirus vaccine shipment offsets earnings miss", "text": "Shares of Moderna Inc. MRNA, +27.81% were up 14% in premarket trading on Wednesday - the day after the biotechnology company said it had shipped the first COVID-19 vaccine candidate to the National Institutes of Health for clinical trials.", "source_name": "Market Watch", "date": "Wed, 26 Feb 2020 07:35:58 -0500", "topics": ["earnings"], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}]}